Objective: Reduction mammaplasty is a common surgical procedure that yields a variable amount of tissue for pathologic examination. The purpose of this study was to evaluate the histological diagnoses of the reduction mammaplasty specimens and to determine the incidence of breast lesions in otherwise asymptomatic and healthy Jordanian females.
Introduction
Reduction mammaplasty is one of the most frequent procedures performed by plastic surgeons all around the world. Patients of different ages undergo this kind of surgery, ranging from adolescents to postmenopausal women.
Three main indications for breast reduction are congenital breast asymmetry, macromastia, and symmetry after an operation for breast cancer. from bra straps, and chronic intertrigo in breast skin folds. Severe breast hypertrophy can limit exercise and daily activities. Reduction mammaplasty has proven to be safe and relieves symptoms, with overall excellent patient satisfaction.
In addition to the reduction of breast size, reduction mammaplasty offers the chance to examine all the resected breast tissue histologically, which may allow detection of premalignant and malignant lesions in otherwise asymptomatic and healthy patients.
Several papers suggesting a link between breast pathology and reduction mammaplasty have been published in recent decades. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [24] [25] [26] [27] [28] Populationbased studies, including surveys of plastic surgeons and analyses of cancer registry data indicate that the incidence of occult invasive breast carcinoma found during breast-reduction is between 0.06 and 2% according to different authors. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [24] [25] [26] [27] [28] In Jordan, breast carcinoma is the main cause of death from cancer in women. In 2007, for example, breast cancer accounted for 35 .8% of all new cases of cancer among Jordanian females and 24.4% of deaths in women caused by cancer in our country. 20 Because of this, it would not be uncommon for the plastic surgeons to find a breast tumor during preoperative investigation, during surgery, or in the post operative period when the histopathological report is received. To our knowledge, there is no study in Jordan addressing pathological evaluation of reduction mammaplasty specimens, hence we conducted a retrospective review of 73 patients who underwent inferior-pedicle technique reduction mammaplasty at Jordan University Hospital over a 10-year period, to determine the incidence of the pathological diagnoses of the resulting specimens and compare them with other studies in the literature. This will lead us to better evaluation, counseling, and management of our patients.
Patients and Methods
This retrospective study included 73 patients who had undergone reduction mammaplasty at the Department of Plastic and Reconstructive Surgery in Jordan University Hospital between September 1999 and September 2009.
One hundred forty three specimens from 73 breasts reductions constituted the basis of this study. The charts of the patients were evaluated for the following: age of the patient, previous breast disease, biopsy, family history, breast cancer risk factors, breast examination, preoperative mammography or ultrasound scanning, weight of the breast specimen, and pathologic findings.
The ages of the patients were divided into four categories: less than 25 years, 26-35 years, 36-45 years, and 46-55 years. All surgical procedures were performed by a single plastic surgeon, using the Wise-pattern inferior-pedicle technique. All resected tissue was forwarded to the pathology laboratory for sectioning and gross examination, including weight and size measurements.
The breasts were placed whole in quite large volumes of 10% buffered formalin for fixation for 24 hrs. Following fixation, each breast was serially sectioned in a sagittal plane at 0.5 mm intervals; it was then closely examined by the pathologist and evaluated slice by slice for any suspicious areas perceived either visually or by touch. If no discrete lesions were identified by gross examination, three to five random samples of representative tissue were taken from each breast, but the number of samples increased to six to ten when abnormal tissues were detected during macroscopical evaluation. The tissue selected for histological evaluation was routinely processed for embedding in paraffin blocks; afterwards each paraffin block was cut into 8 micrometer sections, stained with hematoxylineosin, and evaluated under a light microscopy. Inferential statistics were used to examine differences between patients' pathologic findings where ANOVA, t-test, and nonparametric statistics were used when appropriate. All statistical procedures were performed using α = 0.05, 2-tailed. 
Results
The ages of the patients ranged between 16 and 53 years, with an average of 35 years. Of the 73 patients identified, 70 patients had undergone bilateral reduction mammaplasty, and three patients had undergone unilateral reduction mammaplasty; two patients (ages 36 and 42 years) had a history of modified radical mastectomy because of breast cancer. None of the patients had complaints apart from macromastia and related symptoms, and none of them had risk factors for breast cancer, except two patients with a history of breast carcinoma. The mean breast tissue weight was 1,954 gm (right breast, 1,002 gm; left breast, 956 gm). The mammogram was done to 26 patients above the age of 40 years and two patients with a history of breast cancer. All mammograms were reported as normal in spite of the fact that 20 patients (77%) had pathological findings in their mammary tissue. The microscopic evaluation revealed normal breast tissue in 49% of the patients (n = 36) (figure1). Non-proliferate lesions were identified in 41% of patients (n = 30) (table 3) .
These lesions in declining order of frequency are fibrocystic changes (21%), fibrosis (6.8%), duct ectasia (6.8%), fibro-adenoma (2.7%), adenosis (2.7%), and apocrine metaplasia (1.4%).
Proliferative lesions were noted in 5.4% of the patients (n = 4). These lesions were solitary papilloma in one patient (1.4%) and florid epithelial hyperplasia in three patients (4%). Atypical ductal hyperplasia was represented in 4% of the patients (n = 3). None of our patients had atypical lobular hyperplasia or carcinoma in situ. One patient with a history of breast cancer had normal histology, and the other patient had fibrocystic changes. Incidences of normal, nonproliferative and proliferative breast lesions by age group are outlined in table (4).
Age was a significant factor at the time of breast reduction (figure 2). Younger women (younger than 35 years) were more likely to have normal breast tissue (P = 0.02). Proliferative breast tissue changes were more common in patients older than 35 years. Of those patients who had non-proliferative breast changes (n = 30), 16 patients (53.3%) patients were 36-45 years old. Suspicious firm fibrous lesions were identified intra operatively in two cases. Frozen sections confirmed these lesions to be benign fibrocystic changes. No specimen radiology was done. All patients with atypical ductal hyperplasia were referred to a breast surgeon. 
Discussion
Breast reduction specimens provide an ample tissue for histological evaluation. There is variance in the literature regarding the incidence of different breast lesions diagnosed following reduction mammaplasty. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [24] [25] [26] [27] [28] [29] To the authors' knowledge; this is the first study in Jordan to evaluate the histopathological profile of reduction mammaplasty specimens among Jordanian females. We conducted a retrospective study over a 10-year period at Jordan University Hospital to analyze these pathological diagnoses and compare our results with other studies in the literature. Understanding the incidence of precancerous and cancerous breast lesions in breast reduction patients can help plastic surgeons in the preoperative evaluation and counseling of patients, and in the postoperative management of patients found to have an increased risk of breast cancer. (table 1) . 21 We demonstrated in our study that the majority of patients had normal mammary tissue (49%, n = 36). Fifty eight percent of those patients were 35 years of age or younger. A breast is understood as "normal" when the glandular and ductal elements and the connective tissues do not show morphological changes, with a perfect balance among the different tissues. Some studies support our findings. Bondeson et al. 29 reviewed 200 reduction mammaplasty specimens in which the majority of patients were 30 years of age and younger and found no significant pathologic findings. Similarly, Clark et al. 24 showed that 41.8% of the patients (235 of 562 patients) had normal breast tissue. Furthermore, Ayhan et al. 15 showed in their study on 149 patients who had undergone reduction mammaplasty that 45.0% of the patients had normal breasts.
On the contrary, other studies demonstrated that only a minority of patients had normal mammary tissue. In 1963, Pitanguy and Torres 8 recognized that only 11 of 167 patients (6.6%) who had undergone reduction mammaplasty had normal mammary tissue. In an update of this study in 2005, 19 the authors studied 2,488 patients and demonstrated that only 3.7% of breast reduction patients had normal breast tissue. These contradicting results might be explained by biases in specimen processing and patient sampling and differences in histologic classification criteria. There is variability in the literature in the incidence of non-proliferative breast lesions (table 5) . It ranges between 10.5% and 100%. In our study, 30 patients (41%) had non-proliferative breast lesions.
Again, this wide range in the incidences might be explained by biases in specimens and patients sampling and differences in histologic classification criteria. The most common nonproliferative lesion in our study was fibrocystic disease (21%, n = 15). According to the Cancer Committee of the College of American Pathologists, fibrocystic disease of the breast is an exaggerated physiological phenomenon rather than a disease. 30 It is a benign alteration of the breast tissues (e.g., fibrosis, adenosis, and cystic changes). Although it is impossible to know the precise incidence of fibrocystic changes in the breast, it has been estimated that more than onethird of women between 20 and 45 years of age have some clinical evidence of fibrocystic changes on routine physical examination. 15 In a postmortem study, histologic evidence of fibrocystic changes was found in 54% of clinically normal breasts. 31 Both Pitanguy et al. 19 and Ayhan et al. 15 reported higher incidences of fibrocystic changes compared to our study (36.8% and 46.8%, respectively).
Duct ectasia is a benign condition with the histological changes of major duct dilatation, associated with periductal fibrosis and chronic inflammatory infiltration. The incidence in postmortem studies in women of all ages is 25%. 31 In our study, the incidence of duct ectasia was 6.8% (n = 5). Browing et al. 32 found that in their study on 1,256 female patients who had undergone breast surgery the incidence of duct ectasia was 8.1%, which is close to our figure. In contrast, Viana et al. 25 demonstrated an incidence of 1.7%.
Fibroadenoma is a benign tumor, which predominantly occurs in young women, especially between 20-25 years of age. This tumor is histopathologically characterized by two components: a proliferative stroma of connective fibrosis and one epithelial element (ductal and acini) so that the connective component predominates. The incidence of fibroadenoma is reported to be in 9-25% of normal breasts evaluated microscopically in a post mortem study. 30 In our study, the incidence of fibroadenoma was 2.7% (n = 2). There are some studies in the literature that support our finding. Pitanguy et al. 19 in their study on 2,488 patients who had undergone reduction mammaplasty found an incidence of fibroadenoma of 2.2% (n = 57). Similarly, Ayhan et al. 15 in their study on 149 patients revealed an incidence of 3.1%. Similar incidence (3%) was revealed in Viana et al. 25 study on 274 patients who had undergone reduction mammaplasty.
Adenosis may be defined as the expansion of the lobules with an increased number of ductules or acini within a lobule and considered a component of fibrocystic changes according to some authors. 30 The incidence of adenosis in the autopsy series is between 6.2 and 16.7%. 30 In our series, the incidence was 2.7% (n = 2), which is close to the Ayhan et al. 15 study. However, Viana et al. 25 reported a higher incidence (6.1%) than our study.
Fibrosis of the breast is a benign condition characterized by the proliferation of stroma, with obliteration of the mammary acini and ducts. The incidence of fibrosis in our study was 6.8% (n = 5). Viana et al. 25 in their study on 274 patients who had undergone reduction mammaplasty revealed an incidence of 1.5% (n = 4), which is lower than our study.
Apocrine metaplasia is a benign disease that affects women during their reproductive life in which the acinar cells look like apocrine sweat glands. It is believed to be secondary to an irregular response by breast tissue to hormonal stimuli. It is found in 60-90% of breasts at autopsy. 32 In our study, the incidence of apocrine metaplasia was 1.4% (n = 1). This is close to the Ayhan et al. 15 study in which the incidence was 0.88%. On the other hand, Viana et al. 25 reported a higher incidence in their series (5.2%).
Patients with proliferative lesions in our study constitute 5.4% (n = 4). There was one patient (1.4%) with a solitary papilloma, which is characterized histopathologically by the proliferation of intraductal epithelium that may show a variable degree of cellular atypia, and it is considered a lesion of low malignancy. The incidence of intraductal papilloma in the Ayhan et al. 15 series was 0.68% which is close to our result. Nevertheless, Viana et al. 25 reported a higher incidence of papilloma (4.1%) in their series. Florid epithelial hyperplasia was present in three patients (4%).
This entity increases the risk of the development of breast carcinoma by 1.5-2.0 times .Clark et al. 24 reported an incidence of 4.4% (25 of 562 patients), which is close to our study. However, both Viana et al. 25 and Ayham et al. 15 reported lower incidences compared to our study (2.7% and 1.33%, respectively). Atypical ductal hyperplasia increases the risk of breast cancer by 4-5 times that in the general population. It was represented in 4% (n=3) of our patients whose average age was 46 years. Interestingly, Clark et al., 24 Viana et al., 25 and Ambaye et al. 13 reported lower incidences than our study (0.2%, 0.02%, 0, and 0.6%, respectively). In our study, we did not encounter any case of a typical lobular hyperplasia the same as the Viana et al. 25 study. Pitanguy et al. 19 and Ambaya et al. 13 reported small percentages as well, (0.04% and 0.07%, respectively).
Our study revealed no cases of ductal carcinoma in situ (DCIS), lobular carcinoma in situ (LCIS), or invasive carcinoma. This could probably be explained by the relatively small number of our patients and the low incidence of these lesions in published studies in the literature. The incidences of DCIS, LCIS, and invasive carcinoma in breast reduction specimens reported in the literature is demonstrated in table 5.
The differences in the incidences of breast lesions noticed in the studies of the literature might be explained by biases in the patients' population, the sampling of specimens, and the histologic classification criteria. The role of preoperative mammography in non-oncologic breast surgery is controversial. 34, 35 Few would dispute mammograms for patients over the age of 40 years, in accordance to the general guidelines of American Cancer Society. In 1990, Perras 34 reviewed 1,149 mammograms in patients over the age of 35 or with a positive family history who underwent cosmetic surgery of the breast. Cancer was detected primarily by mammogram in 34 patients; therefore, his department has implemented a policy of mandatory preoperative mammograms before these procedures.
Interestingly, Ambaye et al. 13 found that the majority of patients over the age of 40 (22 of 25 patients) with significant pathologic findings who underwent screening mammograms within the year before reduction mammaplasty, had none of the pathologic findings detected on preoperative mammograms. Similarly, all the 26 patients in our study had normal preoperative mammography in spite of the fact that 20 patients (77%) had pathological changes.
DCIS ductal carcinoma in situ; LCIS, lobular carcinoma in situ

Conclusion
This retrospective study revealed that patients 35 years of age or younger were more likely to have normal mammary tissue. Proliferative and nonproliferative breast lesions were more common in older patients. Fibrocystic disease was the most common benign lesion of the breast. No in situ or invasive carcinoma was identified in our study.
Breast cancer is a major public health problem in Jordan, and as plastic surgeons, we have obligation to actively participate in the health and well being of our patients, and this involves understanding and applying good breast cancer screening practices. Further studies are needed regarding the efficacy of mammography as a screening tool before reduction mammaplasty.
The pathologist has the great challenge of attempting to find small clinically undetected pathology in a large mass of breast tissue and fat; hence, we think that more sampling will lead to an increase in the identification of occult significant pathologic findings. Nevertheless, lack of pathological investigations or hurried examination of any mammary tissue by pathologists may cause important lesions to be overlooked.
Although reduction mammaplasty is not a prophylactic measure in the prevention of breast cancer, there is no doubt that it is a unique opportunity to evaluate with great richness of detail, a patient's breast parenchyma which is especially valuable in women in higher risk groups. 
